Calmodulin (CaM) is the primordial member of a superfamily of EF-hand Ca 2+ binding proteins (CaBPs) that confer Ca 2+ -dependent regulation to a vast array of enzymes, ion channels, and neurotransmitter receptors (1) (2) (3) . Although CaM is ubiquitously expressed in all eukaryotic cells, emerging evidence supports a role for CaBPs other than CaM in the regulation of a number of effectors (4, 5) . CaBP1 represents a subfamily of CaBPs (1) (2) (3) (4) (5) that are highly expressed in the brain and retina (6) . Like CaM, CaBP1 regulates the activity of CaM kinase II, G-protein coupled receptor kinases (6) , inositol trisphosphate receptors (7) (8) (9) , and TRPC5 channels (10) . Unlike CaM, which is ubiquitously expressed in all eukaryotic cells, CaBP1 is found primarily in neurons (6) , and so may play important roles in regulating Ca 2+ -dependent processes, such as synaptic transmission and gene transcription, in the nervous system.
Although nearly 50% identical to CaM at the amino acid level, CaBP1 has effects on voltage-gated Ca 2+ channels that oppose those of CaM (11) (12) (13) . In transfected cells, CaM is constitutively associated with Ca v 1.2 (L-type) Ca 2+ channels, and causes both negative (Ca 2+ -dependent inactivation, CDI) and positive (Ca 2+ -dependent facilitation, CDF) feedback regulation of these channels (14) (15) (16) . In contrast, CaBP1, which colocalizes and coimmunoprecipitates with brain Ca v 1.2 channels, stabilizes channel opening and does not support CDI (17) . Both CaBP1 and CaM bind to the IQ-domain, a site in the Cterminal region of the Ca v 1.2 α 1 -subunit (α 1 1.2) which is critical for CDI (14) (15) (16) (17) Cell culture and transfection 293T cells were maintained in Dulbecco's modified eagle's medium with 10% fetal bovine serum at 37 ºC in a humidified atmosphere under 7% CO 2 . Cells were grown to ~70-80% confluence and transfected with Gene Porter reagent (Gene Therapy Systems, San Diego, CA) according to manufacturer's protocols.
Plate-binding assays
GST-IQ, His-CaBP1, and His-CaM fusion proteins were expressed in BL21 E.coli and purified as described previously (17) . Concentrations of recombinant proteins were determined by a commercial kit (Bio-Rad Laboratories, Hercules, CA). Five pmol of HisCaBP1 or His-CaM was adsorbed to each well of a 96-well plate by incubating overnight at 4 °C. After rinsing wells with TBST (tris-buffered saline (TBS: 20 mM Tris, pH 7.3, 150 mM NaCl) +0.1%TX-100), wells were blocked with 3% milk/TBST for 1 h at room temperature. Wells were then incubated with varying concentrations of GST-IQ fusion proteins or GST as a negative control (100 µl in TBST) for 2 h at room temperature. After washing 3 times with 200 µl TBST, wells were processed with monoclonal anti-GST (Santa Cruz Biotechnology, Santa Cruz, CA, 1:500 in TBST) for 1 h at room temperature. After washing 3 times in TBST, wells were incubated with HRP-conjugated anti-mouse IgG (Amersham Biosciences, Piscataway, NJ, 1:1000 in TBST) for 1 h at room temperature, then washed with TBST and colorimetric reaction product generated with addition of TMB substrate (Vector Laboratories, Burlingame, CA) and H 2 SO 4 . Absorbance was read at 450 nm from a Thermomax microplate reader (Molecular Devices, Sunnyvale, CA). Specific binding was determined by subtracting absorbance values for wells containing GST from those containing GST-IQ.
Pull-down binding assays
CaBP1 used for binding assays was obtained by transfecting 293T cells plated on 150 mm dishes with a total of 5 µg cDNA encoding CaBP1/pcDNA3.1+. Two days later, cells were homogenized in 1 ml of ice-cold lysis buffer (10 mM HEPES, 50 mM NaCl, 1 mM benzamidine, 0.5% Triton X-100, pH 7.4) and membrane proteins solubilized by rotating at 4 °C for 30 min. Insoluble material was removed by ultracentrifugation at 100,000 x g for 30 min and the supernatant was used immediately or aliquotted and stored at -80 ºC. GST-tagged proteins corresponding to cytoplasmic domains of α 1 1.2 were immobilized on glutathione-agarose beads as described previously (17 Coimmunoprecipitation assays. 293T cells were transfected with equimolar amounts of cDNAs encoding Ca v 1.2 subunits (FLAG-α 1 1.2, β 2A , and α 2 δ) with or without CaBP1. At least 48 h later, cell lysates were prepared as described above and incubated with 40 µl of anti-Flag M2 affinity gel (Sigma-Aldrich) for 1 h, rotating at 4 °C. After five washes with 1 ml of lysis buffer, proteins were eluted with sample buffer, subject to SDS-PAGE, and coimmunoprecipitated proteins were detected by Western blotting with anti-CaBP1 (UW72) or monoclonal anti-FLAG antibodies (M2, 1:2000, Sigma) followed by secondary antibodies and ECL detection as described above.
Electrophysiological recordings
For electrophysiological experiments, Ca v 1.2 subunits (FLAG-α 1 1.2 (rbcII), β 2A , and α 2 δ (18-20)) were expressed from the pcDNA3.1+ vector (Invitrogen, Carlsbad, CA). 293T cells plated on 35 mm dishes were transfected with a total of 5 µg DNA including 0.1 µg of a pEGFP-N1 or 0.3 µg CaBP1/pEGFPN1 for fluorescent detection of transfected cells. At least 48 h after transfection, whole-cell patch clamp recordings of transfected cells were acquired with a HEKA EPC-9 patch clamp amplifier (HEKA, Germany). Data acquisition and leak subtraction using a P/-4 protocol were done with Pulse software (HEKA). Extracellular recording solutions contained 150 mM Tris, 2 mM MgCl 2 and 10 mM CaCl 2 or BaCl 2 . Intracellular solutions consisted of 140 mM N-methyl-D-glucamine, 10 mM HEPES, 2 mM MgCl 2 , 2 mM Mg-ATP and 5 mM EGTA. The pH of intracellular and extracellular recording solutions was adjusted to 7.3 with methanesulfonic acid. Electrode resistances were typically 1-2 MΩ in the bath solution and series resistance was ~2-4 MΩ, compensated up to 70%. In recordings of Ba 2+ currents, voltage protocols were adjusted by -10 mV to compensate for the corresponding shift in voltage-dependence of activation with substitution of extracellular Ba 2+ for Ca 2+ . I-V curves were fit by:
where g=maximum conductance, V=test voltage, E=apparent reversal potential, V 1/2 =voltage of halfmaximal activation, and k=slope factor. Data were analyzed using Igor software (Wavemetrics, Lake Oswego, OR) and graphs and statistical analysis were done with Sigma Plot (SPSS, Inc., Chicago, IL). (17) . We further characterized the effects of these IQ mutations on inactivation during sustained depolarizations ( Fig.1 ). To directly compare modulation by CaM and CaBP1 in these experiments, we restricted analysis to Ca 2+ currents (I Ca ), as Ba 2+ currents (I Ba ) show no CaMdependent enhancement of inactivation (14) (15) (16) . Inactivation was expressed as I res /I pk , which is the residual I Ca amplitude at the end of a 1-s test pulse normalized to the peak current amplitude (Fig.1) . In 293T cells transfected with Ca v 1.2 alone, I Ca decays almost completely during the 1-s pulse, due to CDI mediated by endogenous CaM in these cells (Fig.1B) . CaBP1, which is not expressed in 293T cells (17) , overrides the effects of CaM and inhibits inactivation of I Ca , resulting in a significant increase in I res /I pk , compared to Ca v 1.2 alone (~197%, p<0.01). IQ mutations did not prevent the effects of CaBP1 in that I res /I pk was still significantly increased in cells cotransfected with Ca v 1. . These results were confirmed in pull-down assays, where CaBP1 and CaM binding to GST-IQ was decreased by IQ-AA, and eliminated by IQ-EE, substititution (Figs.2B,C). In previous studies, IQ-EE, but not IQ-AA, mutations altered the apparent affinity of Ca 2+ -dependent CaM binding (22, 24) . The ability of IQ-AA to more significantly inhibit CaM binding in our experiments could have resulted from the use of a larger GST-tagged fusion protein (~100 aa) applied in plate-binding and pull-down assays rather than a short (~20 aa) peptide used in gelshift or fluorescence-based assays in previous studies (22, 24 (Fig. 3A,B) . In addition to the IQ-domain, CaM has been shown to interact with both the N-terminal domain (NT) and the cytoplasmic loop connecting domains I and II (LI-II) of α 1 1.2 (21, 25) , and our experiments confirmed these findings (Fig. 3B) . In contrast, CaBP1 did not bind LI-II, but bound specifically to the NT as well as the loop connecting domains III and IV (LIII-IV) (Fig. 3B) Fig. 4 , NT deletion did not significantly affect voltagedependent activation of Ca v 1.2 currents either in the presence or absence of CaBP1. However, NT deletion negated the effect of CaBP1 on I Ca inactivation (Fig.5) . In contrast to the limited inactivation of I Ca evoked by sustained or repetitive depolarizations in cells cotransfected with CaBP1 and Ca v 1.2 (Fig.5A,C) , CaBP1 had no effect on I Ca inactivation in cells cotransfected with Ca v 1.2 ∆NT with either voltage protocol (Fig.  5B,D) . There was no significant difference in I res /I pk over a range of test voltages in cells transfected with Ca v 1.2 ∆NT alone and those cotransfected with CaBP1 (Fig.5B) , eliminating the possibility that deletion of the NT simply altered the voltage-dependence of CaBP1 modulation.
RESULTS

Role of the IQ-domain in
Although Ca v 1.2 ∆NT was completely insensitive to the effects of CaBP1, CDI was still evident in these channels in that inactivation of I Ba was significantly less than that for I Ca in cells transfected with Ca v 1.2 ∆NT (Fig. 5D) Fig. 6A,B) . Moreover, deletion of the NT from channels harboring IQ-EE mutations largely prevented the residual effects of CaBP1 seen in the single mutant Ca v 1.2 IQ-EE channels (I res /I pk = 0.55±0.03, n=11, for Ca v 1.2 ∆NT-IQ-EE alone vs. 0.63±0.04, n=10, for Ca v 1.2 ∆NT-IQ-EE +CaBP1, p=0.15, Fig. 6A,B) . These results clearly showed that the NT is essential for the regulation of I Ca inactivation by CaBP1, but not by CaM.
The residual modulation by CaBP1 (Fig.6C) . However, in cells cotransfected with CaBP1 and Ca v 1.2 ∆NT , CDI was quite robust (~86% increase in I res /I pk for I Ba compared to I Ca , p<0.01, Fig.6C ). These results confirmed that blockade of CDI is secondary to the effects of CaBP1 on slowing I Ca inactivation, and that the NT is required for this process.
Significance of the IQ-domain for physical association of CaBP1 with Ca v 1.2 channels.
Given that CaBP1 binds to the NT and IQ-domain of α 1 1.2, yet only deletion of the NT abolished CaBP1 modulation of Ca v 1.2, we investigated how these two sites contributed to the physical association of CaBP1 with the intact channel. Our pull-down assays suggested that the NT could be a tethering site for CaBP1 while the IQ-domain mediated strictly Ca 2+ -dependent interactions with the channel (Fig.3) (17) , in the present study Ca 2+ -independent coimmunoprecipitation was inconsistent and weak compared to Ca 2+ -dependent interactions (Fig.7) . This difference could have arisen from our efforts to reduce CaBP1 transfected across groups to compensate for the poor expression of the channel due to the IQ-EE mutation. Lower levels of CaBP1 expression could have impaired detection of Ca 2+ -independent binding of CaBP1 to the channel, particularly if such interactions are not of sufficient affinity to withstand the coimmunoprecipitation protocol. Because of this technical limitation, we were unable to address whether the NT was a tethering site for CaBP1 in the channel under Ca 2+ -free conditions. However, in the presence of Ca 2+ , we found that CaBP1 was brought down with α 1 1.2 ∆NT but not with α 1 1.2 IQ-EE (Fig.7) . These data show that the IQ-domain is important for maintaining Ca 2+ -dependent interactions of CaBP1 with the channel complex. Based on our findings that CaBP1 has residual effects on I Ca inactivation in Ca v 1.2 IQ-EE (Figs.1,6 (Fig. 6,7) . Thus, while the IQ-domain is required for the functional effects of CaM in enhancing I Ca inactivation, it is not sufficient for the opposing actions of CaBP1.
Based on previous analyses of CaM interactions with Ca v 1.2 and the biochemical and electrophysiological results in the present study, we propose a working hypothesis for how CaBP1 and CaM differentially influence Ca v 1.2 inactivation (Fig.8) . In cells not expressing CaBP1, CaM is tethered to α 1 1.2 via C-terminal domain sequences, which include the IQ-domain. Although CaM binds in a Ca 2+ -dependent manner to the NT (Fig.3 and (25) ), deletion of the NT does not abolish CDI (Figs.5,6 ). Thus, it is the association of Ca 2+ /CaM with the IQ-domain that is necessary for fast inactivation of I Ca (Fig.8A) . By contrast, in cells that endogenously express CaBP1, such as in the brain or retina (6), CaBP1 may be constitutively associated with the NT, and Ca 2+ influx may strengthen Ca 2+ -dependent interactions of CaBP1 with the channel, which then suppress I Ca inactivation (Fig.8B) . Because IQ-EE mutations impaired Ca 2+ -dependent association of CaBP1 with the channel (Fig.7) , we propose that the IQ-domain, or some structural rearrangement involving the IQ-domain, stabilizes the physical interaction of CaBP1 with the channel. The persistence of slower I Ca inactivation in cells cotransfected with CaBP1 and Ca v 1.2 IQ-EE , but not in Ca v 1.2 ∆NT-IQ-EE (Fig.6A,B) , suggests that CaBP1 interactions with the NT in the absence of a functional IQ domain are sufficient to induce slow I Ca inactivation even though overall interaction with the channel may be weakened. At present, we cannot yet assign the functional importance of the IQ-domain as a CaBP1-binding site. If one assumes that CDI is a specific consequence of CaM at the IQ-domain, then the maintenance of CDI in cells cotransfected with Ca v 1.2 ∆NT and CaBP1 (Fig.6C) could be taken as evidence that CaM is bound to the IQ-domain even when CaBP1 is expressed in the same cell. In this context, it is possible that CaBP1 that coimmunoprecipitated with Ca v 1.2 ∆NT (Fig.7) was mediated by contacts other than the IQ-domain such as LIII-IV of α 1 1.2 (Fig.3) . However, we cannot rule out the possibility that CaBP1 does bind to the IQ-domain and reproduces the effect of CaM in causing CDI, but only when the influence of the NT is removed. Despite the remaining uncertainties about the specific role of CaBP1 binding to the IQ-domain, all of our results are consistent with a model in which the NT of α 1 1.2 is the primary locus by which CaBP1 slows I Ca inactivation and subsequently prevents CDI of Ca v 1.2.
A major assumption is that CaBP1 is constitutively associated with the channel via the NT of α 1 1.2, which is based on our findings that CaBP1 binds to the NT in the presence and absence of Ca 2+ (Fig.3) . In addition, the rapid kinetics of CaBP1 in causing slow inactivation of I Ca , would be inconsistent with Ca 2+ -dependent binding and unbinding from the channel. Unfortunately, our coimmunoprecipitation experiments did not permit detection of such Ca 2+ -independent interactions (Fig.7) . While it seems counterintuitive that Ca 2+ -dependent and not constitutive binding of CaBP1 would be favored in such experiments, we have also not been able to coimmunoprecipitate CaM with Ca v 1.2 (not shown) or Ca v 2.1 (P/Q-type) channels under Ca 2+ -free conditions (11) . Compared to Ca 2+ -activated K + channels, which are tightly associated with Ca 2+ -free (apo)CaM (30), Ca 2+ -independent binding of CaM and CaBP1 to Ca v 1.2 may be of significantly weaker affinity. A second explanation is that N-terminal myristoylation of CaBP1 (6), a modification which mediates its interaction with the plasma membrane (8) The NT of α 1 1.2 as a modulatory site for inactivation. A number of studies implicate a role for the NT of α 1 1.2 in modulating inactivation. Deletion or plasma membrane anchoring of the α 1 1.2 NT severely inhibits Ca 2+ -dependent and voltage-dependent inactivation of Ca v 1.2 when the channels are expressed in the absence of auxiliary β-subunits (31). It has also been proposed that the N-terminal and C-terminal domains of α 1 1.2 interact as an inhibitory scaffold which limits channel gating (25) . CaBP1 binding to the NT of α 1 1.2 may disrupt these inhibitory interactions to stabilize the open state of the channel. While we limited our analyses to the effects of CaBP1 on I Ca and CDI, we do not rule out the possibility that CaBP1 could have additional effects on voltagedependent inactivation, considering that both forms of inactivation employ similar molecular determinants (32, 33) , which include components in the cytoplasmic C-terminal domain of α 1 1.2 and linker connecting domains I and II (29, 34) . Clarification of the precise molecular contacts for CaBP1 interactions with Ca v 1.2 and how such interactions could coordinately disrupt inactivation awaits high-resolution structural analysis and further functional studies.
Splice variant diversity and modulation by CaBP1 and CaM. Alternative splicing of the human α 1 1.2 gives rise to an array of Ca v 1.2 variants with different tissue distributions and functional properties (35) . Splicing of exon 1 yields two α 1 1.2 variants which differ in the length and sequence of the NT region (18, (36) (37) (38) (39) (40) (41) . The long NT variant, originally identified in rabbit heart (37) , contains at the extreme N-terminus a unique 46 amino acid sequence in place of 16 amino acids of the short NT variant (rat brain α 1 1.2) used in our study (39) . CaM was also found to bind to the long NT of the rabbit heart α 1 1.2, and deletion of most of the NT (residues 2-139) from this channel significantly inhibited CDI (25) . Our results confirm these findings, but also show that deletion of the first half of the NT in the rat brain α 1 1.2 has a much smaller effect on CDI mediated by CaM than for CaBP1 suppression of I Ca inactivation (Fig.6 ). It should be noted that our NT deletion removes the first 64 of 124 amino acids that comprise the NT of the rat brain α 1 1.2 so it is possible that CaM could interact with a site in the remaining half of the NT. This would account for the residual CDI in Ca v 1.2 ∆NT (Fig. 6 ) and the more complete block of CDI upon deletion of most of the NT sequence from the rabbit heart α 1 1.2 (25) . Previous studies support a role for the long NT in the upregulation of Ca v 1.2 currents by protein kinase C (42). Since protein kinase C and CaM-dependent regulation of targets is often mutually exclusive (43), the long NT sequence could determine the extent to which Ca v 1.2 channels undergo regulation by CaM and/or CaBP1. Although molecular analyses suggest that the long NT variant is restricted to the heart (35, 40, 41) , immunochemical evidence supports the expression of this variant in the brain (39 
